Your patients are our patients
When Anovo gets a prescription you write, your patient gets the support they need – and you can rest easy. We establish insurance reimbursement, assist with any prior authorization requirements and get the first shipment to the patient’s door quickly.
Our pharmacists and patient support teams are dedicated experts in your patient’s specific disease state and medication, and they work together to ensure that your patient stays on their therapeutic course and receives the benefits and outcomes of the therapy you prescribed.
Prior Authorization Assistance
Your Anovo team understands these processes and will work with you and your clinical staff to help your patients receive the prescribed medication.
We will research your patient’s insurance benefits, which may include commercial insurance, Medicare, Medicaid and other state and local options.
Free Delivery and Overnight Shipping
Anovo will call your patients each month to arrange refill shipments and ship their medication to their preferred delivery location.
Product Information and Expertise
If you have questions about your patient’s medication, simply call Anovo at 1-844-288-5007 to be connected with a pharmacist.
Our Clinical Educator will be there to answer questions, perform regular check-ins, and support your patients in meeting their treatment goals.
ANASCORP is an antivenom indicated for treatment of clinical signs of scorpion envenomation.
ALKINDI SPRINKLE is a corticosteroid indicated as replacement therapy in pediatric patients with adrenocortical insufficiency.
Carglumic Acid tablets for oral suspension are indicated in pediatric and adult patients as adjunctive therapy to standard of care for the treatment of acute hyperammonemia due to NAGS deficiency; and maintenance therapy for the treatment of chronic hyperammonemia due to NAGS deficiency.
CYSTADANE is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations.
CYSTADROPS is a cystine-depleting agent indicated for the treatment of corneal cystine crystal deposits in adults and children with cystinosis.
DAYBUE is indicated for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older.
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older.
FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.
ISTURISA is a cortisol synthesis inhibitor indicated for the treatment of adult patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.
SIGNIFOR is a somatostatin analog indicated for the treatment of adult patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.
SIGNIFOR LAR is a somatostatin analog indicated for the treatment of patients with acromegaly who have had an inadequate response to surgery and/ or for whom surgery is not an option; and for the treatment of patients with Cushing’s disease for whom pituitary surgery is not an option or has not been curative.